title: Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients.
abstract: The purpose of this study was to evaluate the outcome of patients with unresectable hepatocellular carcinoma (HCC) treated by sequential therapy of transcatheter arterial chemoembolization (TACE), three-dimensional conformal radiotherapy (3-DCRT) and high-intensity focused ultrasound (HIFU). From October, 2005 to September, 2010, 120 patients with unresectable HCC received the sequential treatments of several courses of TACE followed in 2-4 weeks by 3-DCRT and then a single session of HIFU with a curative intent. The median tumor irradiation dose was 40 Gy. Tumor response, toxicity and overall survival rate were analyzed. Clinicopathologic factors affecting the primary technique effectiveness and overall survival rates were investigated by univariate analysis or multivariate analysis. All 120 HCC patients were followed up by the last follow-up time. Among these patients, hepatic toxicities due to treatment were notable in 9 cases. Gastrointestinal bleeding after the overall treatment occurred in 2 cases, leukopenia of grade III was detected in 1 case, radiation-induced liver disease (RILD) was observed in 2 patients, and first- and second-degree skin burn around the HIFU treatment zone were observed in 2 patients and 1 patient, respectively. Among 120 patients, 23, 83 and 14 cases achieved partial response, stable disease and progressive disease, respectively. The overall survival rates at 1 year, 3 years and 5 years were 70%, 35% and 15%, respectively, with a median survival time of 26 months. Both Child-Pugh liver function grading and radiation dose were determined to be independent predictors for overall survival revealed by the multivariate analysis. It is concluded that the sequential therapy of TACE, 3-DCRT and HIFU is a promising therapeutic regimen for unresectable HCC.
authors.affiliation: Department of Oncology, the First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
authors.forename: Shengfa
authors.initials: S
authors.lastname: Ni
authors.forename: Lingxiang
authors.initials: L
authors.lastname: Liu
authors.forename: Yongqian
authors.initials: Y
authors.lastname: Shu
keywords: hepatocellular carcinoma; high-intensity focused ultrasound (HIFU); three-dimensional con-formal radiotherapy (3-DCRT); transcatheter arterial chemoembolization (TACE)
references.citation: Radiology. 2005 May;235(2):659-67
references.pmid: 15858105
references.citation: Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1037-42
references.pmid: 17234356
references.citation: J Gastroenterol Hepatol. 2001 Aug;16(8):883-9
references.pmid: 11555102
references.citation: Cancer Treat Rev. 2010 Apr;36(2):157-63
references.pmid: 20031332
references.citation: Ultrasound Med Biol. 2011 Dec;37(12):1993-9
references.pmid: 22036638
references.citation: Eur J Gastroenterol Hepatol. 2006 Jun;18(6):659-72
references.pmid: 16702857
references.citation: J Gastroenterol Hepatol. 2002 Jan;17(1):52-8
references.pmid: 11895553
references.citation: Crit Rev Oncol Hematol. 2008 Aug;67(2):113-23
references.pmid: 18308583
references.citation: Ann Surg Oncol. 2004 Dec;11(12):1061-9
references.pmid: 15545506
references.citation: Ann Surg. 2011 May;253(5):981-7
references.pmid: 21394012
references.citation: Korean J Gastroenterol. 2007 Sep;50(3):176-82
references.pmid: 17885283
references.citation: Radiology. 2003 Aug;228(2):335-45
references.pmid: 12893895
references.citation: Ann Ital Chir. 2008 Mar-Apr;79(2):107-10
references.pmid: 18727272
references.citation: Eur J Surg Oncol. 2011 Mar;37(3):245-51
references.pmid: 21195578
references.citation: Indian J Radiol Imaging. 2011 Apr;21(2):113-20
references.pmid: 21799594
references.citation: Br J Surg. 2003 Mar;90(3):325-31
references.pmid: 12594668
references.citation: J Clin Gastroenterol. 2001 May-Jun;32(5):383-9
references.pmid: 11319307
references.citation: Cancer. 2009 Mar 15;115(6):1245-52
references.pmid: 19156918